Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of England's international ranking in terms of access to new and effective treatments for NHS patients.

The Department has made no assessment of the number of medicines that are available for the treatment of National Health Service patients in England compared with other countries. Analysis from the European Federation of Pharmaceutical Industries and Associations’ Waiting to Access Innovative Therapies Indicators compares availability of new medicines across European countries. The availability in England of medicines that received a European Union marketing authorisation between 2019 and 2022 was slightly higher than the European average.